Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Staskin D et al (2024): Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial
The clean reads were mapped to the human genome (GRCh38) using HISAT2
Description Klow Blend Peptides is a research-grade peptide blend containing four components: GHK-Cu (a copper-binding tripeptide), BPC-157, TB-500 and KPV
Data availability Raw data, and Scaffold results are available from the MassIVE proteomics repository (MSV000083987) and Proteome Exchange PXD014279
US$ 26.33
.webp)
US$ 21.64
US$ 22.71
